Materias dentro de su búsqueda.
Mostrando 833,681 - 833,700 Resultados de 834,362 Para Buscar '"Severance"', tiempo de consulta: 4.07s Limitar resultados
  1. 833681
    “…EXPOSURES: Sociodemographic characteristics, medical risk factors, factors associated with TB severity, and health equity index. MAIN OUTCOMES AND MEASURES: Frequency of reported successive TB and COVID-19 (TB/COVID-19) diagnoses within 120 days, frequency of deaths, and age-adjusted mortality rates. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sociodemographic Characteristics, Comorbidities, and Mortality Among Persons Diagnosed With Tuberculosis and COVID-19 in Close Succession in California, 2020
  2. 833682
    “…Higher TCR scores were associated with measures of disease severity, including abnormal liver function tests, disseminated rash, and number of symptoms. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB17. Immunosequencing of the T-Cell Receptor Repertoire Reveals Signatures Specific for Diagnosis and Characterization of Early Lyme Disease
  3. 833683
    “…CONCLUSION: In N3C, we found that hospitalizations and all-cause mortality were greater among rural populations when compared to urban populations after adjustment for several factors, including age and co-morbidities. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    33. Evaluation of Rural-Urban Differences in Hospitalization and Mortality Rates for US COVID-19 Patients in the United States
  4. 833684
    “…[Image: see text] [Image: see text] [Image: see text] CONCLUSION: Results from the first part of the study indicate that regdanvimab may lower the rate of hospitalisation or requirement of oxygen supplementation, with the greatest benefit noted in patients at high-risk of progressing to severe COVID-19. The second part of the study remains ongoing and blinded. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    546. Therapeutic Effect of Regdanvimab in Patients with Mild to Moderate COVID-19: Day 28 Results from a Multicentre, Randomised, Controlled Pivotal Trial
  5. 833685
    “…Participants were eligible for the study if they had no unstable or severe underlying medical or psychiatric conditions; had no history of a laboratory-confirmed SARS-CoV-2 infection; were not pregnant or breastfeeding; and had no previous receipt of an adenovirus-vectored, coronavirus, or SARS-CoV-2 vaccine. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
  6. 833686
    “…Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased mortality in patients with hematological malignancies, with increase rates between 33-37%. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sars-CoV2 Antibody Responses in Patients with Hematological Malignancies Following Anti-CD20 Therapy
  7. 833687
    “…Neutralizing antibodies and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cells have been detected in convalescent and immunized immunocompetent individuals. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL
  8. 833688
    “…Introduction: In hospitalized patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the frequency of venous thromboembolism (VTE) is increased. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Impact of Degree of Anticoagulation on Thrombotic and Other Complications in Hospitalized COVID-19 Patients
  9. 833689
    “…Despite count recovery, the patient remained positive by nasal/oral PCR swab test for several weeks, delaying the delivery of the second CPX-351 induction cycle. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Successful Treatment of Acute Myeloid Leukemia with CPX-351 in 2 Patients in the United Kingdom during the COVID-19 Pandemic
  10. 833690
    “…Background: Several observational studies have reported the rate of thrombotic events in patients infected with coronavirus disease 2019 (COVID-19), with conflicting results (1). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparison of Thrombotic Complications in Critically Ill Patients between COVID-19 and Mers-COV
  11. 833691
    “…The mRNA vaccines BNT162b2 and mRNA-1273 have robust safety and efficacy with 95-97% prevention of severe COVID-19 disease and development of protective antibody titers in 92 - 100% of healthy individuals. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy
  12. 833692
    “…Since the COVID-19 vaccines have been shown to effectively prevent symptomatic infection including hospital admissions and severe disease, the risk of COVID-19-related thrombosis should be expected to (almost) disappear in vaccinated individuals. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study
  13. 833693
    “…In contrast, persons in other CEV groups were twice as likely to receive a first dose COVID immunization compared to the general BC population (p<0.0001). No severe vaccine-related complications including vaccine-induced immune thrombotic thrombocytopenia (VITT) were reported. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID Vaccination Rates in Children and Adults with Sickle Cell Disease in British Columbia, Canada
  14. 833694
    “…Finally, we could not adequately gauge severity of COVID-19 disease given notable variations in institutional resources. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 in Hospitalized Patients with Sickle Cell Disease
  15. 833695
    “…It is also likely that high levels of monoclonal/oligoclonal anti-PF4 antibodies cause the severe thrombotic phenotypes seen in VITT and Spontaneous HIT. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
  16. 833696
    “…They are at risk to develop severe and/or prolonged forms of Covid-19. The efficacy of vaccination against COVID in lymphoma/CLL patients also raises specific concerns: Antibody response to mRNA COVID-19 vaccine was shown to be negatively affected by CLL stage and its treatments, especially in case of previous administration of anti-CD20 antibodies (Herishanu et al). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Third Anti-Sars-Cov2 mRNA Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy and/or Low Immunoglobulin Level in CLL/Lymphoma Patients
  17. 833697
    “…Recipients of allogeneic hematopoietic stem cell transplant (HSCT) have been excluded from clinical trials of SARS-CoV-2 messenger RNA (mRNA) vaccines; however, since these patients are at higher risk of severe complications following infection, they have been given high priority in vaccination campaigns worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
  18. 833698
    por Perini, Guilherme Fleury, Villela, Luis, Beltran, Brady E, Castro, Denisse, Otero, Victoria, Kalmus, Mariana, Fiad, Lorena, Peña, Camila, Idrobo, Henry, Candelaria, Myrna, Von Glasenapp, Alana, Perdomo, Ivan, Feres, Carolina, Prates, Maria Virginia, Paredes, Sally Rose, Perez-Jacobo, Fernando, Ramirez-Ibarguen, Ana Florencia, Gajardo, Claudia, Salinas, Macarena Alejandra Roa, Otañez, Melani, Valvert, Fabiola, Arcuri, Leonardo Javier, Montaño Figueroa, Efreen, Di Stefano, Marcos, Baena, Rosio, Choque, Juan Antonio, Abello, Virginia, Valladares, Ximena, Sanchez, Sofia, Nancy, Cristaldo, Zambrano, Daniela, Lasso, Juan Felipe, Noboa, Andrea, Rojas, Christine, Teixeira, Larissa LC, Ospina, Juan Alejandro, Torres Viera, Marialejandra Alejandra, Sotomayor, Eduardo, Martinez, Humberto, Castillo, Jorge J., Skarbnik, Alan, Malpica Castillo, Luis
    Publicado 2021
    “…Introduction: Ongoing SARS-COV-2 pandemic has impacted the management of cancer patients worldwide. Several reports have demonstrated inferior outcomes of patients with hematological malignancies, including higher rates of intensive care unit admission, need for mechanical ventilation and death. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell
  19. 833699
    “…Background: The severe, acute respiratory syndrome, coronavirus 2 (SARS-CoV-2), leading to coronavirus-19 (COVID-19), was detected for the first time in Wuhan, China in December 2019. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Impact of the COVID-19 Pandemic on Quality of Life in Danish Patients with Multiple Myeloma; Results from an Ongoing Longitudinal National Survey
  20. 833700
    “…We find substantial gaps in the evidence. Several gender‐related barriers to girls' schooling are under‐examined. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Policies and interventions to remove gender‐related barriers to girls' school participation and learning in low‐ and middle‐income countries: A systematic review of the evidence
Herramientas de búsqueda: RSS